VIENNA (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK.L, HKMPY.PK) announced the Group has agreed to acquire 98.09% of the share capital of EIMC United Pharmaceuticals from a consortium of shareholders. EIMC is a pharmaceutical manufacturing company specialising in oncology products.
Hikma Pharma said the acquisition brings an attractive portfolio and pipeline in the key strategic areas of oncology and injectables, with the potential to add around 50 products by 2020.
Mazen Darwazah, Hikma Vice Chairman, said: 'Egypt is a very important market for Hikma and we have been rapidly growing our business there over the last few years. Acquiring EUP will further strengthen our market position and be a key driver of future growth.'
Copyright RTT News/dpa-AFX
© 2015 AFX News